This downregulation plays a crucial role in the pathogenesis of B-ALL by reducing cell proliferation, hindering cell cycle progression, and promoting apoptosis through the modulation of the ADCY6-RAPGEF3-JNK pathway. The gene discussed is RAPGEF3; the disease is precursor B-cell acute lymphoblastic leukemia.